At a glance
- Originator Aventis
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Leukotriene B4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 10 Oct 1994 Discontinued-Preclinical for Asthma in France (Unknown route)